Skip to content
XOMA
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Contact Us
  • Royalty Portfolio
  • Opportunities
    • Overview
    • Royalty Acquisition
    • Assets Available for Licensing
      • Phage Display Platform
      • Ebopiprant
      • Anti-prolactin Antibody
      • XMetA Portfolio
  • News
    • Company & Partner News
    • Press Releases
  • Investors
    • Overview
    • News & Events
    • Financial Information
    • Stock Data
    • Analyst Coverage
    • SEC Filings
    • Governance
  • Contact
XOMA
XOMA
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Contact Us
  • Royalty Portfolio
  • Opportunities
    • Overview
    • Royalty Acquisition
    • Assets Available for Licensing
      • Phage Display Platform
      • Ebopiprant
      • Anti-prolactin Antibody
      • XMetA Portfolio
  • News
    • Company & Partner News
    • Press Releases
  • Investors
    • Overview
    • News & Events
    • Financial Information
    • Stock Data
    • Analyst Coverage
    • SEC Filings
    • Governance
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Company & Partner News
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Financial Information
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Overview
    • Charts
    • Historical Data
    • IRS Form 8937
  • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents

Press Releases

XOMA Reports Second Quarter 2007 Financial Results

Aug 08, 2007 4:02pm EDT

XOMA Appoints Steven B. Engle President, Chief Executive Officer and Director

Aug 06, 2007 8:15am EDT

XOMA to Present At Canaccord Adams Global Growth Conference On August 9, 2007

Aug 02, 2007 9:00am EDT

XOMA Announces August 8 Conference Call and Webcast Discussion of Second Quarter 2007 Financial Results

Aug 01, 2007 9:00am EDT

XOMA Elects Charles J. Fisher, M.D. to Board of Directors

Jul 26, 2007 8:35am EDT

XOMA Initiates Phase I U.S. Trial in Type 2 Diabetes for XOMA 052, Monoclonal Antibody With Therapeutic Potential in Multiple Inflammatory Diseases

Jul 16, 2007 8:35am EDT

XOMA Reports First Quarter 2007 Results

May 10, 2007 4:00pm EDT

XOMA Executives to Present at BIO2007 Convention, Rodman & Renshaw Global Healthcare, Needham Biotechnology and Jefferies Healthcare Conferences

May 07, 2007 6:30pm EDT

XOMA Announces May 10 Conference Call and Webcast Discussion of First Quarter 2007 Financial Results

Apr 26, 2007 7:01pm EDT

XOMA Announces Clinical Trial Plans for XOMA 052 in Type 2 Diabetes

Apr 12, 2007 9:00am EDT
RSS
  • Prev
    • 1...
    • 38
    • 39
    • 40
    • 41
    • 42
    • 43
    • 44
    • 45
    • 46
    • 47
    Next
    • Email Alerts
    • RSS News Feed
    • Terms of Use

    © 2025 XOMA Royalty Corporation.  All rights reserved.

    All references to “portfolio” on this website refer strictly to milestone and/or royalty rights associated with a basket of drug products in development. All references to “assets” on this website refer strictly to milestone and/or royalty rights associated with individual drug product candidates in development. References to royalties or royalty rates strictly refer to future potential payment streams regardless of whether or not they are technically defined as royalties in the underlying contractual agreement; further, any rates referenced herein are subject to potential future contractual adjustments.

    • Follow us:
    © 2025 XOMA • Powered by GeneratePress
    Scroll back to top